Clinical Trial Update: Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients

View source ↗

Summary

This trial update outlines a study of Turoctocog alfa treatment regimens for Iraqi Haemophilia A patients, and the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• Turoctocog alfa (turoctocog alfa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A | Status: RECRUITING